Annual CFF
$126.53 M
+$72.39 M+133.70%
December 31, 2023
Summary
- As of February 7, 2025, HROW annual cash flow from financing activities is $126.53 million, with the most recent change of +$72.39 million (+133.70%) on December 31, 2023.
- During the last 3 years, HROW annual CFF has risen by +$125.09 million (+8729.59%).
- HROW annual CFF is now at all-time high.
Performance
HROW Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$721.00 K
-$794.00 K-1087.67%
September 30, 2024
Summary
- As of February 7, 2025, HROW quarterly cash flow from financing activities is -$721.00 thousand, with the most recent change of -$794.00 thousand (-1087.67%) on September 30, 2024.
- Over the past year, HROW quarterly CFF has dropped by -$64.92 million (-101.12%).
- HROW quarterly CFF is now -101.12% below its all-time high of $64.19 million, reached on September 30, 2023.
Performance
HROW Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$1.48 M
-$64.92 M-102.32%
September 30, 2024
Summary
- As of February 7, 2025, HROW TTM cash flow from financing activities is -$1.48 million, with the most recent change of -$64.92 million (-102.32%) on September 30, 2024.
- Over the past year, HROW TTM CFF has dropped by -$183.05 million (-100.81%).
- HROW TTM CFF is now -100.81% below its all-time high of $181.57 million, reached on September 30, 2023.
Performance
HROW TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
HROW Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +133.7% | -101.1% | -100.8% |
| 3 y3 years | +8729.6% | -4906.7% | -102.9% |
| 5 y5 years | +2962.9% | +5.3% | -152.0% |
HROW Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +145.8% | -101.1% | +10.9% | -100.8% | at low |
| 5 y | 5-year | at high | >+9999.0% | -101.1% | +10.9% | -100.8% | at low |
| alltime | all time | at high | >+9999.0% | -101.1% | +10.9% | -100.8% | at low |
Harrow Health Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$721.00 K(-1087.7%) | -$1.48 M(-102.3%) |
| Jun 2024 | - | $73.00 K(-109.0%) | $63.44 M(-0.2%) |
| Mar 2024 | - | -$809.00 K(+4394.4%) | $63.56 M(-49.8%) |
| Dec 2023 | $126.53 M(+133.7%) | -$18.00 K(-100.0%) | $126.53 M(-30.3%) |
| Sep 2023 | - | $64.19 M(>+9900.0%) | $181.57 M(+54.7%) |
| Jun 2023 | - | $189.00 K(-99.7%) | $117.38 M(+0.3%) |
| Mar 2023 | - | $62.16 M(+13.0%) | $117.08 M(+116.2%) |
| Dec 2022 | $54.14 M(+5.2%) | $55.03 M(>+9900.0%) | $54.14 M(-6190.1%) |
| Sep 2022 | - | $0.00(-100.0%) | -$889.00 K(+1.7%) |
| Jun 2022 | - | -$111.00 K(-85.7%) | -$874.00 K(-101.7%) |
| Mar 2022 | - | -$776.00 K(>+9900.0%) | $51.48 M(+0.0%) |
| Dec 2021 | $51.47 M(+3491.8%) | -$2000.00(-113.3%) | $51.47 M(+1.5%) |
| Sep 2021 | - | $15.00 K(-100.0%) | $50.70 M(+1.6%) |
| Jun 2021 | - | $52.24 M(-6788.6%) | $49.93 M(+7533.9%) |
| Mar 2021 | - | -$781.00 K(+1.4%) | $654.00 K(-54.4%) |
| Dec 2020 | $1.43 M(-242.4%) | -$770.00 K(+1.2%) | $1.43 M(-49.5%) |
| Sep 2020 | - | -$761.00 K(-125.7%) | $2.84 M(-10.9%) |
| Jun 2020 | - | $2.97 M(<-9900.0%) | $3.19 M(-1455.7%) |
| Mar 2020 | - | -$2000.00(-100.3%) | -$235.00 K(-76.6%) |
| Dec 2019 | -$1.01 M(-124.4%) | $635.00 K(-253.8%) | -$1.01 M(+337.4%) |
| Sep 2019 | - | -$413.00 K(-9.2%) | -$230.00 K(-108.7%) |
| Jun 2019 | - | -$455.00 K(-41.1%) | $2.65 M(-23.3%) |
| Mar 2019 | - | -$773.00 K(-154.8%) | $3.46 M(-16.3%) |
| Dec 2018 | $4.13 M(-16.2%) | $1.41 M(-42.9%) | $4.13 M(+21.0%) |
| Sep 2018 | - | $2.47 M(+607.4%) | $3.42 M(+11.3%) |
| Jun 2018 | - | $349.00 K(-456.1%) | $3.07 M(+46.6%) |
| Mar 2018 | - | -$98.00 K(-114.1%) | $2.09 M(-57.5%) |
| Dec 2017 | $4.93 M(-80.0%) | $695.00 K(-67.3%) | $4.93 M(-62.4%) |
| Sep 2017 | - | $2.12 M(-438.6%) | $13.13 M(+1.1%) |
| Jun 2017 | - | -$627.00 K(-122.9%) | $12.98 M(-4.2%) |
| Mar 2017 | - | $2.74 M(-69.2%) | $13.55 M(-45.1%) |
| Dec 2016 | $24.67 M(+129.6%) | $8.89 M(+350.3%) | $24.67 M(+53.4%) |
| Sep 2016 | - | $1.98 M(-3626.8%) | $16.08 M(+14.4%) |
| Jun 2016 | - | -$56.00 K(-100.4%) | $14.05 M(-42.9%) |
| Mar 2016 | - | $13.86 M(+4504.7%) | $24.61 M(+129.0%) |
| Dec 2015 | $10.75 M | $301.00 K(-657.4%) | $10.75 M(+3.1%) |
| Sep 2015 | - | -$54.00 K(-100.5%) | $10.43 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | $10.51 M(<-9900.0%) | $10.62 M(+4233.1%) |
| Mar 2015 | - | -$5000.00(-72.2%) | $245.00 K(-59.1%) |
| Dec 2014 | $599.00 K(-94.0%) | -$18.00 K(-113.4%) | $599.00 K(-2.9%) |
| Sep 2014 | - | $134.00 K(0.0%) | $617.00 K(+27.7%) |
| Jun 2014 | - | $134.00 K(-61.6%) | $483.00 K(+38.4%) |
| Mar 2014 | - | $349.00 K(>+9900.0%) | $349.00 K(-96.5%) |
| Dec 2013 | $10.05 M(-14.9%) | $0.00(0.0%) | $10.05 M(+3.5%) |
| Sep 2013 | - | $0.00(0.0%) | $9.71 M(-28.9%) |
| Jun 2013 | - | $0.00(-100.0%) | $13.65 M(-36.5%) |
| Mar 2013 | - | $10.05 M(-3044.5%) | $21.51 M(+82.2%) |
| Dec 2012 | $11.81 M(+7991.7%) | -$341.40 K(-108.7%) | $11.81 M(-3.7%) |
| Sep 2012 | - | $3.94 M(-49.8%) | $12.27 M(+46.9%) |
| Jun 2012 | - | $7.85 M(+2143.9%) | $8.35 M(+1584.1%) |
| Mar 2012 | - | $350.00 K(+195.9%) | $495.80 K(+240.1%) |
| Dec 2011 | $145.90 K(-85.4%) | $118.30 K(+330.2%) | $145.80 K(+430.2%) |
| Sep 2011 | - | $27.50 K(>+9900.0%) | $27.50 K(>+9900.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2011 | - | $0.00(0.0%) | $1.00 M(0.0%) |
| Dec 2010 | $1.00 M(+1920.2%) | $0.00(0.0%) | $1.00 M(0.0%) |
| Sep 2010 | - | $0.00(-100.0%) | $1.00 M(-4.7%) |
| Jun 2010 | - | $1.00 M(>+9900.0%) | $1.05 M(+2020.2%) |
| Mar 2010 | - | $0.00(0.0%) | $49.50 K(0.0%) |
| Dec 2009 | $49.50 K(-98.7%) | $0.00(-100.0%) | $49.50 K(0.0%) |
| Sep 2009 | - | $49.50 K(>+9900.0%) | $49.50 K(>+9900.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2008 | $3.94 M(-27.9%) | $0.00(0.0%) | $3.94 M(0.0%) |
| Sep 2008 | - | $0.00(-100.0%) | $3.94 M(0.0%) |
| Jun 2008 | - | $3.98 M(<-9900.0%) | $3.94 M(<-9900.0%) |
| Mar 2008 | - | -$36.20 K(<-9900.0%) | -$36.20 K(<-9900.0%) |
| Dec 2007 | $5.47 M(>+9900.0%) | - | - |
| Aug 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2007 | $0.00(-100.0%) | - | - |
| Feb 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2006 | - | $0.00 | $0.00 |
| May 2006 | $80.00 K | - | - |
FAQ
- What is Harrow Health annual cash flow from financing activities?
- What is the all time high annual CFF for Harrow Health?
- What is Harrow Health annual CFF year-on-year change?
- What is Harrow Health quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Harrow Health?
- What is Harrow Health quarterly CFF year-on-year change?
- What is Harrow Health TTM cash flow from financing activities?
- What is the all time high TTM CFF for Harrow Health?
- What is Harrow Health TTM CFF year-on-year change?
What is Harrow Health annual cash flow from financing activities?
The current annual CFF of HROW is $126.53 M
What is the all time high annual CFF for Harrow Health?
Harrow Health all-time high annual cash flow from financing activities is $126.53 M
What is Harrow Health annual CFF year-on-year change?
Over the past year, HROW annual cash flow from financing activities has changed by +$72.39 M (+133.70%)
What is Harrow Health quarterly cash flow from financing activities?
The current quarterly CFF of HROW is -$721.00 K
What is the all time high quarterly CFF for Harrow Health?
Harrow Health all-time high quarterly cash flow from financing activities is $64.19 M
What is Harrow Health quarterly CFF year-on-year change?
Over the past year, HROW quarterly cash flow from financing activities has changed by -$64.92 M (-101.12%)
What is Harrow Health TTM cash flow from financing activities?
The current TTM CFF of HROW is -$1.48 M
What is the all time high TTM CFF for Harrow Health?
Harrow Health all-time high TTM cash flow from financing activities is $181.57 M
What is Harrow Health TTM CFF year-on-year change?
Over the past year, HROW TTM cash flow from financing activities has changed by -$183.05 M (-100.81%)